NAD-dependent deacetylase sirtuin-1, or sirtuin-1 (Sirt1), is currently one of the targets of interest in the treatment of NAFLD [87] and related conditions. The gene discussed is SIRT1; the disease is metabolic dysfunction-associated steatotic liver disease.